Return On Equity ratio Analysis of CTi Biopharma Corp - Deep Dive
Latest FY ROE
Period Ending - Dec-22
Poor ROE
0
Period Ending - Dec-21
Very Poor ROE
-2599.10
Growth
0 %
Trailing Twelve Months ROE
Period Ending - Dec-22
Poor ROE
0
Most recent Quarter ROE
Period Ending - Mar-23
Poor ROE
0
ROE Analysis of CTi Biopharma Corp
ROE Ratio of CTi Biopharma Corp with value of 0 means is not able to effectively utilize its Shareholders Fund in order to generate a profit in trailing twelve months. |
ROE Ratio of CTi Biopharma Corp with value of 0 means is not able to effectively utilize its Shareholders Fund in order to generate a profit in latest Quarter ending on Mar-23. |
ROE Ratio of CTIC has grown by 0 % Compared to previous Financial Year. |
ROE Ratio with value of 0 was highest in Year Dec-22 in last Five Years. |
ROE Ratio with value of -2599.10 was lowest in Year Dec-21 in last Five Years. |
Latest ROE Ratio with value of 0 is Greater than Average ROE of -589.81 in last five years. |
Other ROE Related Info of CTIC that may interest you.
CTi Biopharma Corp Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
CTIC | 9.09 | 9.09 | 0 % | Biotechnology |
Defination of Return On Equity
The Return on Equity (ROE) is a profitability metric that measures a company's ability to generate profits using its shareholder's fund. ROE is calculated by dividing Net Income by Shareholders' Fund. more ..ROE Related Ratios
ReturnOnAsset | NetProfitMargin |
Tsr Profitability Index
Poor Profitability Stock |
FY - Historical Return On Equity of CTi Biopharma Corp
Period | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
---|---|---|---|---|---|---|---|
ROE | 0 | -2599.10 | -131.03 | -168.95 | -49.95 | -186.45 | -390.49 |
Change | 0 % | -1883.55 % | 22.44 % | -238.20 % | 73.21 % | 52.25 % | -70.13 % |
FY Chart of Return On Equity of CTi Biopharma Corp
Note : All Data Generated at the End of Trading Hours (EOD Data)